HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ENTPD5, an endoplasmic reticulum UDPase, alleviates ER stress induced by protein overloading in AKT-activated cancer cells.

Abstract
PI3 kinase (PI3K) and tensin homolog (PTEN) lipid phosphatase control the level of cellular phosphatidylinositol (3,4,5)-trisphosphate, an activator of AKT kinase that promotes cell growth and survival. Gain-of-function mutations in PI3K and loss-of-function mutations in PTEN that activate AKT are commonly observed in human cancers. The activation of AKT causes increased protein translation and the influx of proteins into the endoplasmic reticulum (ER). The expression of ENTPD5, an ER enzyme, is up-regulated in cancer cell lines and primary human tumor samples in which AKT is activated. ENTPD5 hydrolyzes UDP in the ER to promote protein N-glycosylation and refolding. The elevation of ENTPD5 activity therefore protects AKT-active cancer cells from protein-overloading-induced ER stress and the resulting growth arrest and apoptosis.
AuthorsZ Shen, S Huang, M Fang, X Wang
JournalCold Spring Harbor symposia on quantitative biology (Cold Spring Harb Symp Quant Biol) Vol. 76 Pg. 217-23 ( 2011) ISSN: 1943-4456 [Electronic] United States
PMID22169232 (Publication Type: Journal Article)
Chemical References
  • Oncogene Proteins
  • ErbB Receptors
  • Proto-Oncogene Proteins c-akt
  • ENTPD5 protein, human
  • Pyrophosphatases
  • uridine diphosphatase
Topics
  • Animals
  • Apoptosis
  • Endoplasmic Reticulum (enzymology)
  • Endoplasmic Reticulum Stress
  • Endoplasmic Reticulum-Associated Degradation
  • Enzyme Activation
  • ErbB Receptors (metabolism)
  • Gene Knockdown Techniques
  • Humans
  • Mice
  • Models, Biological
  • Neoplasms (enzymology)
  • Oncogene Proteins (metabolism)
  • Phylogeny
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Pyrophosphatases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: